Skip to main content
Clinical Trials/NCT03554278
NCT03554278
Completed
Not Applicable

Alteration of Stool Microbiota in Preterm Infants Less Than 32 Weeks With Anemia, and Following Blood Transfusion

University of Texas Southwestern Medical Center1 site in 1 country57 target enrollmentOctober 9, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anemia, Neonatal
Sponsor
University of Texas Southwestern Medical Center
Enrollment
57
Locations
1
Primary Endpoint
qRT-PCR (polymerase chain reaction) quantitative stool analysis
Status
Completed
Last Updated
last year

Overview

Brief Summary

This study evaluates the relationship between anemia and stool microbiota in premature infants. It also evaluates the relationship between blood transfusion and stool microbiota.

Detailed Description

Necrotizing enterocolitis (NEC) is a leading cause of death in preterm infants, yet the disease mechanism is not well understood. Among the factors that have been studied are the change in stool microbiota (dysbiosis), severe anemia, and transfusion. Studies suggest that dysbiosis occurs in neonates with NEC. Large studies and meta-analyses have shown a predominance of Gammaproteobacteria, a decrease in Firmicutes, and decreased bacterial diversity in stool from infants with NEC. Studies do not support a relationship between transfusions and NEC since there are conflicting findings on this topic. There is a suggestion, however, that severe anemia may be associated with NEC though this requires further study. No studies have been done evaluating the relationship between anemia and change in stool microbiota, or blood transfusion and change in stool microbiota. This study aims to primarily evaluate the relationship between anemia and stool microbiota, and secondarily evaluate the relationship between transfusion and stool microbiota.

Registry
clinicaltrials.gov
Start Date
October 9, 2018
End Date
October 30, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Julie Mirpuri Hathiramani

Assistant Professor of Medicine

University of Texas Southwestern Medical Center

Eligibility Criteria

Inclusion Criteria

  • Preterm infants less than 32 weeks gestation at birth
  • Age at enrollment between 7 days and less than/equal to 30 days
  • Minimum 100 mL/kg/day enteral feeds

Exclusion Criteria

  • Development of necrotizing enterocolitis (NEC) prior to enrollment
  • Prior surgery
  • Major congenital anomalies
  • Oxygen requirement with FiO2 (fraction of inspired oxygen) \>50% (at time of enrollment)

Outcomes

Primary Outcomes

qRT-PCR (polymerase chain reaction) quantitative stool analysis

Time Frame: qRT-PCR will be analyzed for infant stool samples from enrollment until infants are 38 weeks corrected, or until they are discharged from the hospital. This time frame will be an average of 10 weeks per infant.

Quantify major bacterial groups, including Proteobacteria, Firmicutes, and Bacteroides in stool samples

Secondary Outcomes

  • Alpha diversity(Infant stool samples will be analyzed from enrollment until infants are 38 weeks corrected, or until they are discharged from the hospital. This time frame will be an average of 10 weeks per infant.)

Study Sites (1)

Loading locations...

Similar Trials